Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04443920 · ClinicalTrials.gov registry record · Phase 4
Tranexamic Acid for Total Knee Arthroscopy
A Phase 4 study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 86
- Enrollment target
NCT04443920 is a Phase 4 study that has completed, run by The Miriam Hospital. The registered enrollment target is 86 participants.
The verdict
NCT04443920, a Phase 4 study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 86 participants
- Enrollment target
Study Summary
The purpose of this investigation is to determine the most effective regimen of administration of tranexamic acid to improve clinical outcome among patients undergoing total knee arthroplasty.
Interventions
- DRUG Tranexamic acid (TXA)
- DRUG Placebo Normal Saline (NS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2021-01-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04443920
The ClinicalTrials.gov registry entry for NCT04443920 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tranexamic acid (TXA) is the first listed.
NCT04443920 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04443920 about?
NCT04443920 is a clinical study titled "Tranexamic Acid for Total Knee Arthroscopy". The purpose of this investigation is to determine the most effective regimen of administration of tranexamic acid to improve clinical outcome among patients undergoing total knee arthroplasty.
What is the current status of trial NCT04443920?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 86 participants. The study started on 2019-10-29. Estimated completion is 2021-01-08.
What interventions are being tested in trial NCT04443920?
The interventions under investigation include: Tranexamic acid (TXA) (DRUG), Placebo Normal Saline (NS) (DRUG).
Who is sponsoring clinical trial NCT04443920?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.